Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. The Venowave is a medical compression pump that is lightweight, compact, battery operated, designed to treat and alleviate the symptoms associated with poor circulation.


TSXV:THRM - Post by User

Comment by Smokey1958on Sep 10, 2021 3:26pm
70 Views
Post# 33840978

RE:Power Hour and FOMO

RE:Power Hour and FOMO

Sorry!

That should read October 2, 2020 for the first rapid antigen test to be authorized by the FDA under the EUA. Abbott Labs was first authorized on March 31, 2021.


Smokey1958 wrote: Is that a possibility again today? Barchart has moved from a 72% STRONG BUY for THRM this morning to an 88% STRONG BUY this afternoon ....with a strengthening shorterm outlook. The second resistance level is close and the Ask volumes indicate this could be easily breached.

A HALT (based on positive expectations of course) would be a great start to Monday. It would be interesting to note whether there is a pattern in the day of the week that FDA authorization takes place. Regardless of the 34 rapid antigen test FDA EUA authorizations since March 31, 2021 the only one that has made in roads was Abbott Labs .....and they just completed destroying millions of test components and sent thousands of employees home.

Thete is still much room for another player ....AcuVid???

 

<< Previous
Bullboard Posts
Next >>